Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Shan

Showing results (271-280 of 275) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 275 results.
Virologica Sinica|April 9, 2021
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human PrimatesYan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, et al.
Antiviral Research|June 10, 2017
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus NetworkMatthew T Aliota, Leda Bassit, Shelton S Bradrick, et al.
Mabs|June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Emerging Microbes & Infections|November 26, 2020
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal modelsZe-Jun Wang, Hua-Jun Zhang, Jia Lu, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 28

Showing results (271-280 of 275) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 275 results.
Virologica Sinica|April 9, 2021
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human PrimatesYan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, et al.
Antiviral Research|June 10, 2017
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus NetworkMatthew T Aliota, Leda Bassit, Shelton S Bradrick, et al.
Mabs|June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Emerging Microbes & Infections|November 26, 2020
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal modelsZe-Jun Wang, Hua-Jun Zhang, Jia Lu, et al.
Nature Communications|May 12, 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.
Pageof 28